Maureen Tamuno Now Abuja Investments Company GMD

The group managing director of Abuja Investments Company Limited (AICL), Dr. Maureen Tamuno, has assumed duties following an announcement made by the minister of FCT, Nyesom Wike.
This was disclosed in a statement signed by the head of Public Relations & Communications of the company. According to the statement, Dr. Maureen made history as the first female GMD of AICL in the 30 years of its existence and resumed office following a handover ceremony on Monday, 8th of April 2024.

“Dr. Maureen brings to AICL a wealth of experience in leadership, strategic marketing, and consumer behaviour, along with a profound commitment to excellence and service. Dr. Tamuno is a distinguished alumna of Abubakar Tafawa Balewa University (ATBU), where she earned her degree in Management Studies. Her academic journey continued with a Post-Graduate Diploma in Management, an MBA in Marketing, and a Ph.D. in Marketing from Ebonyi State University.

She also attended Harvard University where she pursued certificates in Global Business Strategy and Sustainable Business Strategy. This solid educational foundation has been the bedrock of her professional success.

“With a career that spans various leadership roles, Dr. Tamuno has demonstrated exceptional skills in diplomacy and governance. As a former top lawmaker in the Rivers State House of Assembly and Nigeria’s High Commissioner to Jamaica, she has shown unwavering dedication to fostering growth and development. Her leadership style is characterized by integrity, innovation, and a deep-seated desire to empower others.

“As CEO, Dr. Tamuno envisions AICL as a beacon of sustainable investment, driving growth not only in F.C.T but across Nigeria and beyond. In her inaugural speech, Dr. Tamuno emphasised her commitment to an open-door policy to all staff and urged the AICL team to operate at the highest standard of transparency, confidentiality, accountability, and ethical business practices. Her strategic approach and consumer-centric philosophy are expected to propel AICL to new heights of success.”